The Trajectory of Blood Pressure During Pregnancy in Assisted Reproductive Females
Launched by THE SECOND HOSPITAL OF SHANDONG UNIVERSITY · May 18, 2024
Trial Information
Current as of February 08, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how blood pressure changes during pregnancy in women who became pregnant through assisted reproductive technologies (like in vitro fertilization) compared to women who conceived naturally. Researchers found that women using assisted reproductive technologies have a higher risk of developing high blood pressure and conditions like gestational hypertension and preeclampsia during pregnancy. The goal of the study is to closely monitor blood pressure and other related factors to identify any risks early on, allowing for better care and healthier outcomes for both mothers and their babies.
To participate in this study, women need to be at least 18 years old and must have either undergone assisted reproductive technology and achieved clinical pregnancy or conceived naturally. Those with certain health issues, such as pre-existing high blood pressure or serious illnesses, will not be eligible to join. Participants will have their blood pressure monitored throughout the pregnancy, and this information will help improve care for future mothers who use assisted reproductive technologies. It's important to note that the study is currently recruiting participants, and anyone interested should consult their healthcare provider for more information.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- -Exposure group:
- Mother: Seen in the obstetrics department of our hospital and meet the following conditions at the same time:
- • 1. Complete at least one cycle of IVF or ICSI, PGD or IVM treatment (including natural cycles);
- • 2. Clinical pregnancy was obtained after treatment. Offspring: Offspring born after in vitro fertilization-embryo transfer technique.
- * Non-exposed group:
- • Mother: A mother who conceived naturally. Offspring: 1) Offspring born by natural pregnancy. 2) Offspring born from natural pregnancy of exposed mothers.
- Exclusion Criteria:
- • Unwilling to participate in this research;
- • Unable to participate in this study due to special reasons, such as death, immigration, loss to follow-up;
- • Hereditary diseases, mental diseases, malignant tumors, pre-pregnancy hypertension, uterine malformations and other reproductive organ malformations;
- • Pregnant women who voluntarily terminate pregnancy due to non-preeclampsia factors;
About The Second Hospital Of Shandong University
The Second Hospital of Shandong University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to improving patient outcomes by exploring new therapeutic interventions and enhancing existing treatment protocols. With a multidisciplinary approach and a robust infrastructure, the institution facilitates rigorous scientific inquiry while adhering to the highest ethical standards. The Second Hospital of Shandong University actively collaborates with researchers and healthcare professionals to contribute to the global body of medical knowledge and to ensure the delivery of safe and effective care to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, , China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0